*Annual targets assume a constant (linear) rate of change from the observed baseline (2017) to the 2025 goal (2023 data year). Reduce reported rate ‡ of hepatitis C-related deaths among non-Hispanic Black persons by ≥30% Reduce reported rate ‡ of hepatitis C-related deaths among American Indian and Alaska Native persons by ≥30% Reduce reported rate ‡ of hepatitis C-related deaths by ≥20% Reduce reported rate ‡ of new hepatitis C virus infections among persons who inject drugs ¶ by ≥25% Reduce estimated † new hepatitis C virus infections by ≥20% Reduce reported rate ‡ of hepatitis B-related deaths among Asian and Pacific Islander persons by ≥25% Reduce reported rate ‡of hepatitis B-related deaths by ≥20% Reduce reported rate ‡ of new hepatitis B virus infections among persons who inject drugs ¶ by ≥25% Reduce estimated † new hepatitis B virus infections by ≥20% Reduce estimated † new hepatitis A virus infections by ≥40% Seven standardized viral hepatitis indicators Select the indicator from the table below for more information. Ten indicators provide an objective way to assess progress toward achieving key viral hepatitis goals. In 2020, CDC modified the goals and associated targets from previous reports to align them with CDC’s Division of Viral Hepatitis 2025 Strategic Plan pdf icon and HHS’s Viral Hepatitis National Strategic Plan external icon for 2021-2025. The National Viral Hepatitis Progress Report provides information on progress in the implementation of recommended interventions and the impact these interventions are having on prevention of viral hepatitis transmission, disease, and associated mortality. The Centers for Disease Control and Prevention (CDC) strives to prevent viral hepatitis infections and eliminate disease and mortality caused by viral hepatitis.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |